Manasamitra Vatakam on Scopolamine-Induced Amnesia in Female Wistar Rats

A Sankar1, Deepa Kandasamy2, Sumathi Jones3

  • 1Department of General Medicine, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India.

Abstract

Insights

Manasa Mitra Vatakam (MMV) effectively reversed scopolamine-induced memory loss in rats. This study suggests MMV has memory-enhancing properties for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Neurodegenerative diseases often cause amnesia, with limited treatment options.
  • Scopolamine is a common agent used to induce amnesia in research models.

Purpose of the Study:

  • To evaluate the efficacy of Manasa Mitra Vatakam (MMV) in ameliorating scopolamine-induced memory loss.
  • To assess the memory-enhancing effects of MMV in female Wistar rats.

Main Methods:

  • Behavioral parameters were assessed using the elevated plus maze (also known as Hebb-William maze or rectangular maze).
  • Locomotor activity was measured in female Wistar rats.
  • MMV was compared against Donepezil (DPZ) as a standard treatment.

Main Results:

  • MMV demonstrated significant effectiveness in reversing memory dysfunction caused by scopolamine.
  • The study confirmed the memory-enhancing effects of MMV.

Conclusions:

  • MMV shows potential as a therapeutic agent for memory impairment.
  • This research opens avenues for investigating MMV in central nervous system (CNS) disorders and drug-induced neurotoxicity.